methyl 3β-methoxylup-20(29)-en-28-oate | 173106-57-5

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: methyl 3β-methoxylup-20(29)-en-28-oate
• 英文别名: methyl 3-O-methylbetulinate；3β-3-methoxylup-20(29)-en-28-oic acid methyl ester；methyl (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-methoxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate
• CAS: 173106-57-5
• 化学式: C₃₂H₅₂O₃
• 分子量: 484.763
• InChiKey: SSWFYEJPOCBAIR-BWXYOZBYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  9.1
• 重原子数：
  35
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.91
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl 3β-methoxylup-20(29)-en-28-oate 在 lithium iodide 作用下， 反应 7.0h， 以82%的产率得到3β-methoxylup-20(29)-en-28-oic acid
  参考文献：
  名称：

  Betulinic Acid Derivatives:  A New Class of Human Immunodeficiency Virus Type 1 Specific Inhibitors with a New Mode of Action

  摘要：

  A series of omega-undecanoic amides of lup-20(29)-en-28-oic acid derivatives were synthesized and evaluated for activity in CEM 4 and MT-4 cell cultures against human immunodeficiency virus type 1 (HIV-1) strain IIIB/LAI. The potent HIV inhibitors which emerged, compounds 5a, 16a, and 17b, were all derivatives of betulinic acid (3 beta-hydroxylup-20(29)-en-28-oic acid). No activity was found against HIV-2 strain ROD. Compound 5a showed no inhibition of HIV-1 reverse transcriptase activity with poly(C). oligo(dG) as template/primer, nor did it inhibit HIV-1 protease. Additional mechanistic studies revealed that this class of compounds interfere with HIV-1 entry in the cells at a postbinding step.

  DOI：

  10.1021/jm950670t
• 作为产物：
  描述：

  白桦脂酸 、 碘甲烷 在 sodium hydride 作用下， 生成 methyl 3β-methoxylup-20(29)-en-28-oate
  参考文献：
  名称：

  Betulinic Acid Derivatives:  A New Class of Human Immunodeficiency Virus Type 1 Specific Inhibitors with a New Mode of Action

  摘要：

  A series of omega-undecanoic amides of lup-20(29)-en-28-oic acid derivatives were synthesized and evaluated for activity in CEM 4 and MT-4 cell cultures against human immunodeficiency virus type 1 (HIV-1) strain IIIB/LAI. The potent HIV inhibitors which emerged, compounds 5a, 16a, and 17b, were all derivatives of betulinic acid (3 beta-hydroxylup-20(29)-en-28-oic acid). No activity was found against HIV-2 strain ROD. Compound 5a showed no inhibition of HIV-1 reverse transcriptase activity with poly(C). oligo(dG) as template/primer, nor did it inhibit HIV-1 protease. Additional mechanistic studies revealed that this class of compounds interfere with HIV-1 entry in the cells at a postbinding step.

  DOI：

  10.1021/jm950670t

文献信息

• Triterpenoid derivatives
  申请人：——

  公开号：US20040087560A1

  公开（公告）日：2004-05-06

  The present invention relates to the use of a compound of formula (I), or a pharmaceutically acceptable salt, crystal form, complex, hydrate, or hydrolysable ester thereof, in the preparation of a medicament for treating a patient suffering from leukaemia, cancer or other proliferative disorder. A further embodiment relates to the use a compound of formula (I) in an assay for detecting the phosphorylation state of cellular substrates. The present invention also relates to novel compounds of formula (I), and the chemical synthesis thereof. 1

  本发明涉及使用式(I)的化合物，或其药用可接受的盐、结晶形式、复合物、水合物或可水解酯，在制备用于治疗患有白血病、癌症或其他增值性疾病的患者的药物中的用途。另一实施例涉及在检测细胞底物的磷酸化状态的测定中使用式(I)的化合物。本发明还涉及式(I)的新化合物及其化学合成。
• BETULINIC ACID AND DERIVATIVES THEREOF USEFUL FOR THE TREATMENT OF NEUROECTODERMAL TUMORS
  申请人：Deutsches KrebsforschungszentrumStiftung des öffentlichen Rechts

  公开号：EP1124842A1

  公开（公告）日：2001-08-22
• TRITERPENOID DERIVATIVES
  申请人：Univerzita palackeho V Olomouci

  公开号：EP1292562A1

  公开（公告）日：2003-03-19
• US6369109B1
  申请人：——

  公开号：US6369109B1

  公开（公告）日：2002-04-09
• US7858606B2
  申请人：——

  公开号：US7858606B2

  公开（公告）日：2010-12-28